Liquid chromatography-mass spectrometric analysis of puerarin and its metabolite in human urine

A specific LC-MS method was developed that allowed simultaneous determination of puerarin (PU) and its major metabolite, daidzein (DA), in human urine samples. PU and DA were separated on a packed capillary ODS column with on column concentration. Identification and quantification of the analytes were performed with ESI-Q-TOF mass spectroscopy in negative ionization mode. The method was validated, yielding calibration curves with correlation coefficients greater than 0.998. The LOQ for PU and DA from human urine samples was 0.1 and 0.05 nmol/mL, respectively. Assay accuracy and precision of quality control samples were within +/- 15%. Recoveries of PU and DA in spiked samples were in the range of 79.6-90.4 and 82.3-92.4%, respectively.     

HPLC同时检测血清和尿样中肌酐、假尿苷、尿酸

用反相高效液相色谱法同时测定了３９例糖尿病患者的血清和尿样中的假尿嘧啶核苷、肌酐和尿酸,并与２４ｈ尿白蛋白排泄量进行了比较分析。发现血清假尿嘧啶核苷是糖尿病肾病早期诊断的一种新颖而敏感的指标,有助于连续监测肾脏的功能状态以了解病程的转归。     

Estimation of chromium in ores and beneficiated products: an ultrasonic approach

Cr(III) slowly forms a violet complex with EDTA at pH 3.5 +/- 0.2 under normal conditions. The complex formation can be catalyzed by irradiating the reacting mixture with ultrasonic waves. Quantitative formation of the complex was possible with ultrasonic waves of 15 W/cm(2) intensity within 7.5 min of sonication. This method may be successfully applied to the determination of chromium in ores and beneficiated products containing 20-60% Cr(2)O(3) without separating the analyte from the matrix elements.     

Application of sample pre-oxidation of arsenite in human urine prior to speciation via on-line photo-oxidation with membrane hydride generation and ICP-MS detection

A pre-oxidation procedure which converts arsenite [As(III)] into arsenate [As(v)] was investigated in urinary arsenic speciation prior to on-line photo-oxidation hydride generation with ICP-MS detection. This sample pre-oxidation method eliminates As(III) and As(v) preservation concerns and simplifies the chromatographic separation. Four oxidants, Cl2, MnO2, H2O2 and I3-, were investigated. Chlorine (ClO-aq) and MnO2 selectively converted As(III) into As(v) in pure water samples, but the conversion was inefficient in the complex urine matrix. Oxidation of As(III) by H2O2 was least affected by the urine matrix, but the removal of excess H2O2 at pH 10 proved difficult. The most appropriate oxidant for the selective conversion of As(III) into As(v) with minimal interference from the urine matrix is I3- at pH 7. Unlike H2O2, excess oxidant can be easily removed by the addition of S2O3(2-). The I3-(-)S2O3(2-) treatment on a fortified sample of reconstituted NIST SRM 2670 freeze dried urine indicated that arsenobetaine (AsB), dimethlyarsinic acid (DMA), monomethylarsonic acid (MMA) and As(v) were not chemically degraded with recoveries ranging from 95 to 102% for all arsenicals. Sample clean-up involved pH adjustment prior to C18 filtration in order to achieve efficient As(III) conversion and quantitative recoveries of AsB and DMA. The concentrations determined in NIST SRM 2670 freeze dried urine were AsB 17.2 +/- 0.5, DMA 56 +/- 4 and MMA 10.3 +/- 0.3 with a combined total of 83 +/- 5 micrograms L-1 (+/- 2 sigma).     

Cr^3^+的水解聚合作用IV.两种"根+节"体系之间的过渡状态

The hydrolytic polymerization of chromium (III) ion in 0.040, 0.060, 0.080 and 0.160M Cr(NO3)3 solutions was studied pH-metrically in the medium of 0.5M NaNO3 at 40+/-1 C. The average number of OH- bound per Cr^3^+ at different pH was designated as Z, the gighest value of Z was found to be about 1.0. A family of curves of Z(pH)B, each at a definite concentration B of Cr(NO3)3, was obtained. The values of both B and pH were determined from the curves and a linear relationship between -lgB and pH was found for each value of Z. From the slope of each curve of-lgB(pH)z, a value of t was obtained, which increased from 1.51 to 2.06 when Z increased from 0.10 to 1.0. This implied that the polymerized hudrolysis products were of mixed types. The data of different Z value were treated by three different methods, namely, "core + links" method, project strip method and "homoligand formation constant" method. The results obtained showed the existence of "core + links" compounds not only with two hydroxyl bridges as Cr (Cr(OH)2)n^(^3^+^n^)^+(n = 1,2,3) but also with both one and two hydroxy bridges as Cr3(OH)3, indicating that the present system was a transition from t = 2 to t = 1. The hydrolysis constants of the above compounds are as follows: lgβ = -4.19, lgβ33 = -5.28, lgβ = -8.23, lgβ64 = 12.28. The above results are in agreement with those obtained at low and medium concentration of Cr(NO3)3. Furthermore, the constants obtained by means of different methods are in good agreement with each other as well as with those reported in previous papers.     

Polyacrylic acid-modified alumina for solid-phase extraction and preconcentration of trace iron and chromium from plant samples

A new method is presented for simultaneous preconcentration of trace Fe(III) and Cr(III) by using polyacrylic acid-alumina as a sorbent. The separation/preconcentration conditions of analytes were investigated, including effect of pH, flow rate, elution conditions, sample volume, and interfering ions. At pH 4, the maximum sorption capacities of Fe3+ and Cr3+ were 8.0 and 13.0 mg/g, respectively, by the column method. The linearity was maintained in the concentration range of 0.175-6.0 x 10(3) ng/mL for iron and 0.175-8.0 x 10(3) ng/mL for chromium in the original solution. The RSD values under optimum conditions were +/- 1.73 and +/- 1.28% for 2.0 microg/mL Fe and Cr, respectively. The preconcentration factor was 400 for both of the elements, and detection limits were 0.025 and 0.023 ng/mL for Fe and Cr in the original solutions. The proposed method was successfully applied to the determination of trace amounts of Fe and Cr in plant samples.     

Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine

An automated high-performance liquid chromatographic (HPLC) method has been developed for measurement of 5-S-cysteinyl-DOPA in urine (DOPA = 3,4-dihydroxyphenylalanine). The urinary sample was injected into an HPLC boronate column. With a mobile phase of 0.1 M phosphate buffer containing 0.2 mM disodium ethylenediaminetetraacetate (Na2EDTA) (pH 6.0) mixed with methanol (9:1), 5-S-cysteinyl-DOPA was adsorbed while most other compounds were washed away. By column switching, the column flow was reversed and 5-S-cysteinyl-DOPA was desorbed by a mobile phase of 0.1 M formic acid and 0.2 mM Na2EDTA at pH 3.0 and chromatographed on a reversed-phase column. The precision, as estimated from repeated analysis of an urinary sample and from duplicate analysis of a number of samples, ranged from 1.4 to 5.2% (coefficient of variation), and the analytical recovery was 93 +/- 4.1%. The method is suitable for use in the clinical laboratory.     

Development and application of stir bar sorptive extraction with polyurethane foams for the determination of testosterone and methenolone in urine matrices

This work describes the development, validation, and application of a novel methodology for the determination of testosterone and methenolone in urine matrices by stir bar sorptive extraction using polyurethane foams [SBSE(PU)] followed by liquid desorption and high-performance liquid chromatography with diode array detection. The methodology was optimized in terms of extraction time, agitation speed, pH, ionic strength and organic modifier, as well as back-extraction solvent and desorption time. Under optimized experimental conditions, convenient accuracy were achieved with average recoveries of 49.7 8.6% for testosterone and 54.2 ± 4.7% for methenolone. Additionally, the methodology showed good precision (<9%), excellent linear dynamic ranges (>0.9963) and convenient detection limits (0.2-0.3 μg/L). When comparing the efficiency obtained by SBSE(PU) and with the conventional polydimethylsiloxane phase [SBSE(PDMS)], yields up to four-fold higher are attained for the former, under the same experimental conditions. The application of the proposed methodology for the analysis of testosterone and methenolone in urine matrices showed negligible matrix effects and good analytical performance.     

Characterization of tumorous and normal tissue using a pH-sensitive fluorescence indicator (5,6-carboxyfluorescein) in vivo.

The pH of the interstitial fluid of malignant tumours tends to be lower than that of normal tissue and is depressed by glucose administration. This study aimed to evaluate the effectiveness of dual-wavelength fluorometry using a pH-dependent indicator (5,6-carboxyfluorescein: 5,6-CF) for the detection of tumour areas in vivo. 5,6-CF has two main characteristics: it has two wavelengths of maximum absorbance (465 and 490 nm) and its fluorescence emission (maximum, 515 nm) increases as a function of pH in the physiological pH range of 6-7.4. The experimental study was performed on 28 CDF mice bearing lymphoid leukaemia P388 grafted subcutaneously. The tissue pH values were evaluated from the ratio of the fluorescence intensities (I490/I465) on the basis of a calibration curve linking pH measurements performed within the tissue using a microelectrode and values of the fluorescence intensity ratio. The fluorescence intensity reached its maximum value 60 min after 5,6-CF and glucose administration, followed by a plateau (90 min) when the ratios remained constant at 1.79 +/- 0.05 for normal tissue and 1.35 +/- 0.04 for tumour tissue (p less than 0.005). These results were correlated with the pH measurements in accordance with the calibration curve. This study validates the relevance of dual-wavelength fluorometry using a pH-dependent indicator to characterize in vivo normal and tumour tissues after glucose administration.     

Multi-residue determination of veterinary drugs in milk by ultra-high-pressure liquid chromatography-tandem mass spectrometry

Stir bar sorptive extraction with polyurethane (PU) and polydimethylsiloxane (PDMS) polymeric phases followed by high-performance liquid chromatography with diode array detection [SBSE(PU or PDMS)/HPLC-DAD] was studied for the determination of six acidic pharmaceuticals [o-acetylsalicylic acid (ACA), ibuprofen (IBU), diclofenac sodium (DIC), naproxen (NAP), mefenamic acid (MEF) and gemfibrozil (GEM)], selected as non-steroidal acidic anti-inflammatory drugs and lipid regulators model compounds in environmental water matrices. The main parameters affecting the efficiency of the proposed methodology are fully discussed. Assays performed on 25 mL of water samples spiked at the 10 microg L(-1) level under optimized experimental conditions, yielded recoveries ranging from 45.3+/-9.0% (ACA) to 90.6+/-7.2% (IBU) by SBSE(PU) and 9.8+/-1.6% (NAP) to 73.4+/-5.0% (GEM) by SBSE(PDMS), where the former polymeric phase presented a better affinity to extract these target analytes from water matrices at the trace level. The methodology showed also excellent linear dynamic ranges for the six acidic pharmaceuticals studied, with correlation coefficients higher than 0.9976, limits of detection and quantification between 0.40-1.7 microg L(-1) and 1.5-5.8 microg L(-1), respectively, and suitable precision (RSD <15%). Moreover, the developed methodology was applied for the determination of these target analytes in several environmental matrices, including river, sea and wastewater samples, having achieved good performance and moderate matrix effects. In short, the PU foams demonstrated to be an excellent alternative for the enrichment of the more polar metabolites from water matrices by SBSE, overcoming the limitations of the conventional PDMS phase.     

Separation and speciation of Cr(III) and Cr(VI) with Saccharomyces cerevisiae immobilized on sepiolite and determination of both species in water by FAAS

A rapid, sensitive and accurate method for the separation, preconcentration and determination of Cr(III) and Cr(VI) in water samples is described. Chromium species can be separated by biosorption on Saccharomyces cerevisiae immobilized on sepiolite and determined by flame atomic absorption spectrometry (FAAS). The optimum conditions for separation and preconcentration (pH, bed height, flow rate and volume of sample solution) were evaluated. Recovery of the chromium was 96.3+/-0.2% at 95% confidence level. The breakthrough capacity of the adsorbent was found as 228 mumol g(-1) for Cr(III). The proposed method was applied successfully to the determination of Cr(III) and Cr(VI) in spiked and river water samples.     

Extraction mechanism of Cr(VI) on the aqueous two-phase system of tetrabutylammonium bromide and (NH(4))(2)SO(4) mixture

An aqueous two-phase system of tetrabutylammonium bromide (TBAB) and (NH(4))(2)SO(4) mixture has been developed for the extractive preconcentration and separation of certain compounds. TBAB concentration in upper phase is much higher than that of bottom solution. This new aqueous two-phase system is proposed for the highly selective extraction of Cr(VI) from large amounts of Cr(3+). The Cr(VI) is found to be extracted into the TBAB-rich upper phase due to ion pair formation such as HCrO(4)(-) . TBAB(+). The Cr(VI) was sufficiently extracted into the upper phase in the pH range from 1 to 5. The proposed method has been applied to the determination of trace of Cr(VI) in wastewater samples with a coefficient of variation less than 3.2%. The recovery obtained was not lower than 90%. The determination limit for the Cr(VI) was found to be 60 mug l(-1) in 10 ml of sample solution.     

Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum

A spectrofluorimetric method to determine the antibiotic moxifloxacin is proposed and was applied to pharmaceuticals, human urine and serum. The fluorimetric method allows the determination of 30-300 ng mL-1 moxifloxacin in aqueous solution containing phosphoric acid-phosphate buffer (pH 8.3) with lambda exc = 287 nm and lambda em = 465 nm. Detection and quantification limits were 10 and 30 ng mL-1, respectively, with a relative standard deviation (n = 10) of 2%. This method was applied to the determination of moxifloxacin in three Spanish commercial pharmaceutical formulations. Another variant of the method in micellar medium allows the direct measurement of moxifloxacin in human serum and urine by standard additions. The enhanced fluorescence of moxifloxacin in 8 mM sodium dodecyl sulfate (SDS) solution at pH 4.0 (acetic acid-acetate buffer) for lambda exc = 294 nm and lambda em = 503 nm shows the same linear range as the aqueous method with a 25% lower slope (with detection and quantification limits of 15 and 60 ng mL-1, respectively, and a relative standard deviation of 1.3%), but permits the background fluorescence for urine and serum blanks to be minimized. Hence, sufficient sensitivity is reached to determine therapeutic concentrations of the drug in urine (average recovery 102 +/- 2%) and serum (average recovery 105 +/- 2%) samples.     

Determination of polyamines in urine of normal human and cancer patients by capillary gas chromatography

A capillary gas chromatographic method is described for the determination of polyamines (putrescine, spermidine and spermine) in the urine of normal human and cancer patients. Morning urine after acid hydrolysis is cleaned up on a silica gel column and derivatized with trifluoroacetic-anhydride. Creatinine in human urine is used as internal standard. Recoveries of polyamines are 96.7% putrescine, 102.6% spermidine (Spd), and 98.7% spermine. SD of the method for Spd is 1.949 +/- 0.041 (micrograms/mg creatinine, mean +/- SD, n = 5). The results show that the mean level of polyamines in cancer patients urine is much higher than that in normal human urine. The mean of total polyamines in the normal human and the cancer patients is 2.01 and 44.74, respectively (g/mg creatinine).     

Quantitative determination of indapamide in pharmaceuticals and urine by high-performance liquid chromatography with amperometric detection.

A high-performance liquid chromatographic method with amperometric detection for the determination of the diuretic indapamide using a muBondapak C18 column is developed. The mobile phase consists of an acetonitrile-water mixture (45:55, 5 mM) in KH2PO4-K2HPO4 (pH 4.0). The compound is monitored at +1200 mV with an amperometric detector equipped with a glassy carbon working electrode. A liquid-liquid or solid-liquid extraction is performed prior to chromatographic analysis to avoid the interferences found in urine matrix. Percentages of recovery are 88.3 +/- 5.6 and 82.9 +/- 7.8 for liquid-liquid and solid-liquid extraction, respectively. The developed method has a linear concentration range from 25 to 315 ng/mL with a reproducibility in terms of relative standard deviation of 4% for a concentration level of 0.5 microgram/mL and a quantitation limit of 1 ng/mL. The method is applied to the determination of indapamide in tablets and urine obtained from hypertensive patients after the ingestion of Tertensif (indapamide 2.5 mg).     

对甲氧基苯磺酰氯柱前衍生测定尿中游离羟脯氨酸与脯氨酸

以对甲氧基苯磺酰氯为衍生试剂,建立了分离测定人尿中游离羟脯氨酸和脯氨酸的高效液相色谱方法。考察了衍生温度、衍生缓冲液pH值、衍生时间、衍生剂用量对衍生反应的影响以及流动相组成、流动相缓冲液浓度、pH值和柱温对分离的影响。在优化条件下,羟脯氨酸和脯氨酸分别在5～100μmol/L和5～250μmol/L范围内呈良好线性,相关系数分别为0.999 4、0.999 5,检出限(S/N=3)分别为0.50 nmol/L和0.20 nmol/L,回收率(n=5)分别为95%～99%和96%～102%,相对标准偏差分别为2.1%～4.3%和2.0%～4.8%。该方法可用于人尿中游离羟脯氨酸和脯氨酸的定性定量分析。     

高效液相色谱法同时测定尿中新喋呤和生物喋呤

建立了同时分离检测尿中新喋呤（neopterin,NP）和生物喋呤(biopterin,BP)的高效液相色谱（HPLC）-荧光检测方法。采用Hypersil BDS C18柱、甲醇-水(体积比为10∶90)流动相(流速0.5 mL/min)、激发波长360 nm、发射波长 440 nm、柱温20 ℃的色谱条件,同时分离测定了尿中的NP和BP。尿标本经三氯乙酸处理,在4 ℃下,以12000 r/min的速率离心15 min,上清液用碱中和后,取30　μL直接进样。研究结果表明,NP的线性范围为0.12～10     

A quantitative extraction method for the determination of trace amounts of both butyl- and phenyltin compounds in sediments by gas chromatography-inductively coupled plasma mass spectrometry

A simple and reliable extraction method was developed for quantitative determination of both butyl- and phenyltin compounds in sediments by capillary gas chromatography combined with inductively coupled plasma mass spectrometry (GC-ICP-MS). Both types of organotin compounds were extracted quantitatively from sediment by mechanical shaking into tropolone-toluene and HCl-methanol. After phase separation and pH adjustment, these organotins were ethylated with sodium tetraethylborate. The method was evaluated by analyzing PACS-2 and NIES No. 12 sediment certified reference materials. The dibutyltin (DBT; 1.14 +/- 0.02 micrograms g-1) and tributyltin (TBT; 1.01 +/- 0.04 micrograms g-1) values observed in PACS-2 sediment closely matched the certified values (DBT, 1.09 +/- 0.15; TBT, 0.98 +/- 0.13 microgram g-1 as tin). The monobutyltin (MBT) value was higher (0.62 +/- 0.02 microgram g-1) by more than two fold over the reference value (0.3 microgram g-1 as tin). The concentrations of TBT (0.18 +/- 0.04 microgram g-1) and triphenyltin (TPhT; 0.0099 +/- 0.002 microgram g-1) in the NIES No. 12 sediment were also in good agreement with the certified and reference values of TBT (0.19 +/- 0.03 microgram g-1 as compound) and TPhT (0.008 microgram g-1 as compound), respectively. Recoveries of TBT, tripentyltin (TPeT) and TPhT from spiked sediments were satisfactory (TBT, 102 +/- 3.4%; TPrT, 96 +/- 3.4%; TPhT, 99 +/- 8.5%). The detection limits as tin were in the range 0.23-0.48 ng g-1 for a 0.5 g sample size. It is also noteworthy that clean-up of the extract is not necessary because of the superior selectivity of ICP-MS detection. The present method was successfully applied to marine sediment samples.     

A solid phase extraction reversed-phase HPLC method for the simultaneous determination of methoprene, permethrin and selected metabolites in rat plasma and urine.

A method was validated and applied for the analysis of the insect growth regulator methoprene [Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate], its metabolite methoprene acid, the insecticide permethrin [3-(2,2-dichloro-ethenyl)-2,2-dimethylcyclopropanecarboxylic acid(3-phenoxyphenyl)methylester], and two of its metabolites, m-phenoxybenzyl alcohol and m-phenoxybenzoic acid, in rat plasma and urine using solid-phase extraction and reversed-phase high performance liquid chromatography. The analytes were separated using gradient of 55-100% acetonitrile in water (pH 4.0) at a flow rate ranging between 0.6 and 1.0 mL/min over a period of 20 min, and UV detection at 210 and 254 nm. The retention times ranged from 7.3 to 18.4 min. The limits of detection ranged between 50 and 100 ng/ml, while limits of quantitation were 100-150 ng/mL. Average percentage recovery of five spiked plasma samples was 83.6 +/- 3.9, 80.1 +/- 5.4, 82.1 +/- 4.4, 83.7 +/- 3.9 and 83.1 +/- 4.7, and from urine 79.3 +/- 4.3, 82.0 +/- 5.4, 80.7 +/- 4.2, 78.9 +/- 5.7 and 83.9 +/- 4.5 for methoprene, methoprene acid, permethrin, m-phenoxybenzyl alcohol and m-phenoxybenzoic acid, respectively. The method was linear and reproducible over the range of 100-1000 ng/mL. This method was applied to analyze the above chemicals and metabolites following their combined administration in rats.